Abstract
Elastic liposomes have been developed and evaluated as novel topical and transdermal delivery systems. They are similar to conventional liposomes but with the incorporation of an edge activator in the lipid bilayer structure to provide elasticity. Elastic liposomes are applied non-occluded to the skin and have been shown to permeate through the stratum corneum lipid lamellar regions as a result of the hydration or osmotic force in the skin. They have been investigated as drug carriers for a range of small molecules, peptides, proteins and vaccines, both in vitro and in vivo. Following topical application, structural changes in the stratum corneum have been identified and intact elastic liposomes visualised within the stratum corneum lipid lamellar regions, but no intact liposomes have been identified in the deeper viable tissues. The method by which they transport their drug payload into and through the skin has been investigated but remains an area of contention. This chapter provides an overview of the development, characterisation and evaluation of elastic liposomes for delivery into and via the skin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Honeywell-Nguyen PL, Bouwstra JA (2005) Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol 2(1):67–74
Dubey V, Mishra D, Nahar M, Jain NK (2007) Vesicles as tools for the modulation of skin permeability. Expert Opin Drug Deliv 4(6):579–593
Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM (2007) Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 332(1–2):1–16
Cevc G, Blume G (2001) New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim Biophys Acta 1514(2):191–205
El Maghraby GM, Williams AC, Barry BW (1999) Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol 51(10):1123–1134
Trotta M, Peira E, Carlotti ME, Gallarate M (2004) Deformable liposomes for dermal administration of methotrexate. Int J Pharm 270(1–2):119–125
Cevc G (2003) Transdermal drug delivery of insulin with ultradeformable carriers. Clin Pharmacokinet 42(5):461–474
Cevc G, Blume G (1992) Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1104(1):226–232
Cevc G, Mazgareanu S, Rother M (2008) Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels. Int J Pharm 360(1–2):29–39
Cevc G, Mazgareanu S, Rother M, Vierl U (2008) Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations. Int J Pharm 359(1–2):190–197
Boinpally RR, Zhou SL, Poondru S, Devraj G, Jasti BR (2003) Lecithin vesicles for topical delivery of diclofenac. Eur J Pharm Biopharm 56(3):389–392
Bouwstra JA, De Graaff A, Groenink W, Honeywell L (2002) Elastic vesicles: interaction with human skin and drug transport. Cell Mol Biol Lett 7(2):222–223
Honeywell-Nguyen PL, Gooris GS, Bouwstra JA (2004) Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. J Invest Dermatol 123(5):902–910
Cevc G, Schatzlein A, Blume G (1995) Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J Control Rel 36:3–16
Cevc G (1996) Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 13(3–4):257–388
Cevc G, Blume G, Schatzlein A, Gebauer D, Paul A (1996) The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv Drug Deliv Rev 18(3):349–378
Cevc G, Schatzlein A, Richardsen H (2002) Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta 1564(1):21–30
Honeywell-Nguyen PL, Wouter Groenink HW, de Graaff AM, Bouwstra JA (2003) The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application. J Control Rel 90(2):243–255
van den Bergh BA, Vroom J, Gerritsen H, Junginger HE, Bouwstra JA (1999) Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. Biochim Biophys Acta 1461(1):155–173
van den Bergh BA, Bouwstra JA, Junginger HE, Wertz PW (1999) Elasticity of vesicles affects hairless mouse skin structure and permeability. J Control Rel 62(3):367–379
Trotta M, Peira E, Debernardi F, Gallarate M (2002) Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 241(2):319–327
El Maghraby GM, Williams AC, Barry BW (2000) Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm 204(1–2):159–169
El Maghraby GM, Williams AC, Barry BW (2000) Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm 196(1):63–74
Song YK, Kim CK (2006) Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials 27(2):271–280
Kirjavainen M, Urtti A, Jaaskelainen I, Suhonen TM, Paronen P, Valjakka-Koskela R et al (1996) Interaction of liposomes with human skin in vitro – the influence of lipid composition and structure. Biochim Biophys Acta 1304(3):179–189
El Maghraby GM, Williams AC, Barry BW (2004) Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm 276(1–2):143–161
Jain S, Sapre R, Tiwary AK, Jain NK (2005) Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: development, characterization, and performance evaluation. AAPS PharmSciTech 6(3):E513–E522
Cevc G, Blume G, Schatzlein A (1997) Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo. J Control Rel 45(3):211–226
Honeywell-Nguyen PL, Bouwstra JA (2003) The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action. J Control Rel 86(1):145–156
Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM (2006) Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm 322(1–2):60–66
Dubey V, Mishra D, Asthana A, Jain NK (2006) Transdermal delivery of a pineal hormone: melatonin via elastic liposomes. Biomaterials 27(18):3491–3496
Fry DW, White JC, Goldman ID (1978) Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem 90(2):809–815
Kligman A, Christophers E (1963) Preparation of isolated sheets of human stratum corneum. Arch Dermatol 88:70–73
Cevc G, Vierl U, Mazgareanu S (2008) Functional characterisation of novel analgesic product based on self-regulating drug carriers. Int J Pharm 360(1–2):18–28
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Benson, H.A.E. (2010). Elastic Liposomes for Topical and Transdermal Drug Delivery. In: Weissig, V. (eds) Liposomes. Methods in Molecular Biology, vol 605. Humana Press. https://doi.org/10.1007/978-1-60327-360-2_4
Download citation
DOI: https://doi.org/10.1007/978-1-60327-360-2_4
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-359-6
Online ISBN: 978-1-60327-360-2
eBook Packages: Springer Protocols